Cañete Ochoa, J., Fernández Lanza, F., De Santiago, M. (Coords.): Premios Cervantes. Discursos, 1976-1990

Autor: Luis Armando González

Publikováno v: Realidad, Iss 91 (2003)

No hay resúmenes disponibles Realidad: Revista de Ciencias Sociales y Humanidades No. 91, 2003: 161-163

Externí odkaz: https://doaj.org/article/688a2057c1a344b5abd1e979db4162d9

Testing low-risk bioactive compounds on Halyomorpha halys: an improved pipeline of analyses to investigate their effects on the bacterial endosymbiont Candidatus Pantoea carbekii.

Autor: Checchia I; Department of Biotechnology, University of Verona, Verona, Italy., Andreolli M; Department of Biotechnology, University of Verona, Verona, Italy.; VUCC-DBT Verona University Culture Collection, Department of Biotechnology, University of Verona, Verona, Italy., Lanza F; Agrea Contract Research Organization, San Giovanni Lupatoto, Italy., Santoiemma G; Department of Agronomy, Food, Natural Resources, Animals and Environment (DAFNAE), University of Padova, Legnaro, Italy., Mori N; Department of Biotechnology, University of Verona, Verona, Italy., Pasini M; Agrea Contract Research Organization, San Giovanni Lupatoto, Italy., Lampis S; Department of Biotechnology, University of Verona, Verona, Italy.; VUCC-DBT Verona University Culture Collection, Department of Biotechnology, University of Verona, Verona, Italy., Felis GE; Department of Biotechnology, University of Verona, Verona, Italy.; VUCC-DBT Verona University Culture Collection, Department of Biotechnology, University of Verona, Verona, Italy.

Publikováno v: Pest management science [Pest Manag Sci] 2024 Nov 25. Date of Electronic Publication: 2024 Nov 25.

Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria.

Autor: Kulasekararaj A; King's College Hospital NHS Foundation Trust, National Institute of Health Research/Wellcome King's Clinical Research Facility and King's College London, London, UK., Lanza F; Hematology Unit, Hospital of Ravenna, University of Bologna, Bologna, Italy., Arvanitakis A; Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Haematology, Oncology and Radiation Physics, Skane University Hospital, Malmo, Sweden., Langemeijer S; Department of Hematology, Radboud Universitair Medisch Centrum, Nijmegen, The Netherlands., Chonat S; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Tombak A; Internal Medicine - Hematology Department, Mersin University, Mersin, Turkey., Hanes V; Amgen Inc, Thousand Oaks, California, USA., Cao J; Amgen Inc, Thousand Oaks, California, USA., Miller MJ; Amgen Inc, Thousand Oaks, California, USA., Colbert A; Amgen Inc, Thousand Oaks, California, USA., Shander B; Amgen Inc, Thousand Oaks, California, USA., Mytych DT; Amgen Inc, Thousand Oaks, California, USA., Chow V; Amgen Inc, Thousand Oaks, California, USA., Henary H; Amgen Inc, Thousand Oaks, California, USA.

Publikováno v: American journal of hematology [Am J Hematol] 2024 Nov; Vol. 99 (11), pp. 2108-2117. Date of Electronic Publication: 2024 Aug 22.

Long-term survival can be achieved in a significant fraction of older patients with core binding factor acute myeloid leukemia treated with intensive chemotherapy.

Autor: Mosna F; Hematology and BMTU, Hospital Hospital of Bolzano (SABES - ASDAA), Teaching Hospital of Paracelsus Medical University (PUM), Bolzano (BZ)., Borlenghi E; UOC Ematologia, ASST Spedali Civili, Brescia., Litzow M; Division of Hematology, Mayo Clinic, Rochester Minnesota., Byrd JC; Department of Internal Medicine, University of Cincinnati, Cincinnati Ohio., Papayannidis C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seragnoli', Bologna., Tecchio C; Hematology and Bone Marrow Transplantation Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine, University of Verona., Ferrara F; Hematology, Ospedale 'Antonio Cardarelli', Napoli., Marcucci G; Dept. of Hematological Malignancies Translational Science, City of Hope, Duarte California., Cairoli R; Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano., Morgan EA; Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston Massachusetts., Gurrieri C; Hematology, Azienda Ospedaliera di Padova, Padua., Yeung CCS; Translational Science and Therapeutics Division, Fred Hutchinson Cencer Center, Seattle, WA., Deeg HJ; Translational Science and Therapeutics Division, Fred Hutchinson Cencer Center, Seattle, WA., Capelli D; Ospedali Riuniti di Ancona - Azienda Ospedaliero Universitaria delle Marche, Ancona., Candoni A; Hematology, Azienda Ospedaliero-Universitaria di Udine, Udine., Gotlib JR; Hematology, Stanford Cancer Center Palo Alto, Palo Alto California., Lunghi M; Hematology, AOU Maggiore della Carità, Novara., Pullarkat S; Department of Pathology, David Geffen School of Medicine at UCLA, Los Angeles CA., Lanza F; Dip DIMEC-Universita' degli Studi di Bologna, UO Ematologia - Rete Trapianti CSE Romagna and Centro Studi Clinici Fase 1, Ospedale di Ravenna., Galimberti S; Hematology, Department of Clinical and Experimental Medicine, University of Pisa., Forghieri F; Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena., Venditti A; Hematology, Dept. of Biomedicine and Prevention, University 'Tor Vergata', Rome., Festuccia M; Hematology, Azienda USL della Valle d'Aosta, Aosta., Audisio E; Hematology, Città della Salute e della Scienza di Torino, University of Turin, Torino., Marvalle D; Hematology and Cellular Therapy, Ospedale Mazzoni, Ascoli Piceno., Rigolin GM; Hematology, Azienda Ospedaliero Universitaria 'S. Anna', Ferrara., Roti G; Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma., DiBona E; Hematology, Ospedale 'San Bortolo', Azienda ULSS8 Berica, Vicenza., Visani G; Hematology, Hematology, AST1, Pesaro., Albano F; Hematology and Stem Cell Transplant Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari 'Aldo Moro', Bari., Eisfeld AK; Clara D. Bloomfield Center for Leukemia Outcomes Research, 31Division of Hematology, Department of Internal Medicine, The Ohio State Universisty, Columbus, Ohio., Valent P; Department of Internal Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria; Ludwig Boltzmann Institute for Hematology and Oncoloy, Medical University of Vienna, Vienna., Huls G; Hematology, University of Groningen, Groningen., Borthakur G; Dept. Of Leukemia, MD Anderson Cancer Center, Houston Texas., Krampera M; Hematology and Bone Marrow Transplantation Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine, University of Verona., Martinelli G; Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', IRST-IRCCS Meldola., Kröger N; Dept. of Stem Cell Transplantation with Research Dept. Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, Hamburg., Sperotto A; Oncohematology, Dept. Of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua., Gottardi M; Oncohematology, Dept. Of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua. michele.gottardi@iov.veneto.it.

Publikováno v: Haematologica [Haematologica] 2024 Oct 10. Date of Electronic Publication: 2024 Oct 10.

Plaquettes sanguines de culture : état de l’art

Autor: Strassel, C., Lanza, F., Gachet, C.

Publikováno v: In Bulletin de l'Académie Nationale de Médecine December 2020 204(9):971-980